Key Points
UBS maintained Neutral rating while raising price target to $100.
RBC Capital kept Outperform rating and increased target to $114.
Wall Street consensus shows 7 Buy, 5 Hold ratings with no Sells.
Meyka AI grades CHD as B+ with solid fundamentals and 25.9% net income growth.
Analyst ratings for Church & Dwight remain steady even as major firms boost their price targets. On May 4, 2026, both UBS and RBC Capital maintained their existing analyst ratings while raising bullish price forecasts. UBS kept its Neutral stance but lifted the target to $100 from $98. RBC Capital held its Outperform rating and increased its target to $114 from $112. These analyst rating maintained positions reflect confidence in the household products maker’s fundamentals, despite recent stock weakness. CHD trades at $92.89, down 3.26% on the day.
Analyst Rating Maintained with Higher Price Targets
UBS Raises Target While Keeping Neutral Stance
UBS maintained its Neutral analyst rating on Church & Dwight while raising the price target to $100 from $98. This move signals measured optimism about the company’s near-term prospects. The $2 increase reflects analyst confidence in CHD’s ability to execute its strategy. At $92.89, the stock trades below the new target, suggesting potential upside. UBS’s analyst rating maintained approach balances growth opportunities against valuation concerns in the consumer defensive sector.
RBC Capital Boosts Target to $114 Under Outperform
RBC Capital raised its price target to $114 from $112 while keeping its Outperform rating intact. The $2 increase reflects RBC’s confidence in CHD’s long-term value creation. This analyst rating maintained at Outperform suggests RBC sees meaningful upside from current levels. The $114 target implies 22.7% upside from today’s price. Both firms’ actions underscore steady conviction in Church & Dwight’s household brands portfolio.
Church & Dwight Stock Performance and Market Position
Current Trading Dynamics
Church & Dwight trades at $92.89 after declining 3.26% today. The stock has fallen 3.2% over five days and 7.6% in three months. However, year-to-date performance shows a gain of 10.8%. The company’s market cap stands at $22 billion, reflecting its position as a major consumer staples player. Trading volume reached 2.8 million shares, slightly below the 2.1 million average. The stock’s 52-week range spans $81.33 to $106.04, placing current levels near the lower end.
Analyst Consensus and Broader Coverage
Wall Street consensus shows 7 Buy ratings, 5 Hold ratings, and no Sell recommendations. This analyst rating maintained environment reflects broad support for CHD. The consensus score of 3.0 leans toward Buy. Meyka AI rates CHD with a grade of B+, reflecting solid fundamentals and growth prospects. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.
Financial Metrics and Valuation
Key Financial Ratios
Church & Dwight trades at a P/E ratio of 29.8x, above the S&P 500 average but reasonable for a defensive consumer stock. The price-to-sales ratio stands at 3.5x, reflecting premium valuation. Free cash flow yield is 0.49%, while dividend yield is 1.29%. The company’s debt-to-equity ratio is 0.57x, indicating moderate leverage. Return on equity reaches 17.4%, showing solid profitability. These metrics support the analyst rating maintained stance from both UBS and RBC.
Growth and Profitability Trends
CHD posted 1.6% revenue growth in the latest fiscal year, with net income climbing 25.9%. Operating income surged 33.5%, demonstrating operational leverage. EPS grew 27.2%, outpacing revenue growth. The company generates $5.1 billion in annual operating cash flow and $4.5 billion in free cash flow. Gross margins stand at 45%, while net margins reach 11.8%. These strong fundamentals justify the analyst rating maintained approach and support higher price targets.
Meyka AI Stock Grade and Forecast Outlook
Meyka Grade Breakdown
Meyka AI assigns CHD a B+ grade with a score of 78.5 out of 100. This grade reflects balanced strength across multiple dimensions. The grading methodology weighs S&P 500 benchmark comparison at 11%, sector comparison at 16%, industry comparison at 16%, financial growth at 12%, key metrics at 16%, forecasts at 8%, analyst consensus at 14%, and fundamental growth at 7%. The B+ rating suggests CHD is a solid holding with moderate upside potential. This aligns with the analyst rating maintained positions from UBS and RBC.
Price Forecasts and Technical Setup
Meyka’s AI-powered market analysis platform forecasts CHD at $97.51 monthly and $95.57 yearly. The three-year forecast is $94.08, suggesting modest appreciation. Technical indicators show RSI at 41.2, indicating oversold conditions. The CCI at -117.2 confirms oversold status. Bollinger Bands place the stock near the lower band at $92.33, suggesting potential bounce. These technical signals support the analyst rating maintained thesis, as oversold conditions often precede rebounds.
Final Thoughts
Church & Dwight’s analyst rating maintained status reflects Wall Street’s confidence in the company’s defensive positioning and brand strength. UBS and RBC Capital both raised price targets while keeping their ratings steady, signaling measured optimism. The company’s solid fundamentals, including 25.9% net income growth and strong free cash flow generation, support the bullish case. At $92.89, CHD trades below both new price targets, offering potential upside for investors. The B+ Meyka grade and broad analyst support underscore the stock’s appeal in the consumer defensive sector. Investors should monitor earnings due July 31 for updates on execution and guidance.
FAQs
UBS maintained a Neutral analyst rating while raising its price target to $100 from $98. This analyst rating maintained approach reflects measured confidence in CHD’s fundamentals despite valuation concerns in the consumer defensive sector.
No. RBC Capital kept its Outperform analyst rating intact while raising the price target to $114 from $112. This analyst rating maintained at Outperform suggests RBC sees meaningful upside potential from current stock levels.
Wall Street consensus shows 7 Buy ratings, 5 Hold ratings, and zero Sell recommendations. The consensus score is 3.0, leaning toward Buy. This analyst rating maintained environment reflects broad support for CHD among equity research teams.
Meyka AI rates CHD with a B+ grade, scoring 78.5 out of 100. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.
CHD trades at $92.89, down 3.26% today. The company’s market cap is $22 billion. The stock has declined 7.6% over three months but gained 10.8% year-to-date, reflecting mixed recent performance.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)